logo
logo

Evernow Raises $28.5M In Series A Funding To Redefine Menopause Treatment

Apr 06, 2022•over 3 years ago

Amount Raised

$28.5 Million

Round Type

series a

San Francisco

Description

Evernow, a telehealth company dedicated to using science to transform care for women in perimenopause and menopause, announces today $28.5M in Series A funding led by global venture capital firm NEA with participation from 8VC, Refactor Capital, Coelius Capital, and other institutional investors as well as notable angel investors Gwyneth Paltrow, Carla Harris, Drew Barrymore, Cameron Diaz, Othman Laraki, and others. The new infusion of capital will be used for expanding the team, building member community, and leveraging the company's extensive data and research to focus on product development. In conjunction with the financing, Evernow is launching a new look and feel to enhance the delivery of its science-based care model.

Company Information

Company

Evernow

Location

San Francisco, California, United States

About

Evernow is a company focused on helping women live longer, healthier lives. We're starting with menopause because that's exactly where the healthcare system typically stops, despite the fact that midlife is when so many women are just hitting their stride. Through our site, we deliver 24/7 supportive care for the short and long-term health changes that accompany perimenopause and menopause anchored in access to a core offering of thoroughly researched hormone therapy plans, an expert clinical team, and a responsive approach founded on careful listening. Our goal? To build a new way of delivering healthcare based on science, innovation, and women's lived experience with menopause.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech